CVE-2026-94033

LOWCVSS 3.5/10

Last modified

CVE-2026-94033 is a low-severity vulnerability rated 3.5/10 on the CVSS scale. A vulnerability has been found in SourceCodester Drug Recommendation System 1.0. This vulnerability affects unknown code of the file /drug_recommender/Admin/add_user of the component User Management.

Description

A vulnerability has been found in SourceCodester Drug Recommendation System 1.0. This vulnerability affects unknown code of the file /drug_recommender/Admin/add_user of the component User Management. Such manipulation of the argument txtname/txtemail/txtpassword leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used.

Metrics

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
SourceCodesterDrug Recommendation System1.0

References

Timeline

Published
Last Modified
Status
Received

Frequently Asked Questions

What is CVE-2026-94033?
A vulnerability has been found in SourceCodester Drug Recommendation System 1.0. This vulnerability affects unknown code of the file /drug_recommender/Admin/add_user of the component User Management. Such manipulation of the argument txtname/txtemail/txtpassword leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used.
How severe is CVE-2026-94033?
CVE-2026-94033 has a CVSS score of 3.5/10 (LOW severity).
How do I fix CVE-2026-94033?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-94033?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST